Transdermal buprenorphine for oropharyngeal mucositis-associated pain in patients treated with radiotherapy for head and neck cancer.
Alessandra
A
Huscher
Agostina
A
De Stefani
Ilaria
I
Smussi
Paolo
P
Borghetti
Nadia
N
Pasinetti
Bartolomea
B
Bonetti
Stefano M
SM
Magrini
D000279:Administration, Cutaneous; D002047:Buprenorphine / Q000008:administration & dosage / Q000627:therapeutic use*; D005260:Female; D006258:Head and Neck Neoplasms / Q000532:radiotherapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009294:Narcotics / Q000008:administration & dosage / Q000627:therapeutic use*; D009960:Oropharynx / Q000473:pathology*; D010146:Pain / Q000188:drug therapy* / Q000209:etiology; D010147:Pain Measurement; D013280:Stomatitis / Q000188:drug therapy / Q000209:etiology*
D009294:Narcotics; D002047:Buprenorphine